难治性心源性休克患者从外周静脉-动脉体外膜氧合转换为中央体外膜氧合:结局与桥接策略
该回顾性单中心研究纳入2006年2月至2023年1月ECMO专用ICU中因难治性心源性休克接受外周V-A ECMO并转换为中央ECMO的80例患者,中位年龄44岁。难治性肺水肿是主要转换原因。30例(38%)成功桥接:心脏移植16/80(20%)、心功能恢复10/80(12%)、心室辅助装置4/30(5%);其余50/80(62%)在中央ECMO上死亡。院内和1年生存率分别为31%和27%。心肌梗死作为难治性心源性休克病因是唯一与院内死亡独立相关的变量(HR 2.5,95%CI 1.3-4.9,p=0.009)。作者认为,对经过高度选择、有真实心功能恢复或心脏移植机会的年轻患者,从失败的外周ECMO转为中央ECMO作为决策桥接是可行策略,可避免浪费昂贵有限的资源。
要点
- 转换原因以难治性肺水肿为主;80例中30例(38%)成功桥接至心脏移植、恢复或VAD,50例(62%)在中央ECMO上死亡。
- 院内生存率31%,1年生存率27%;心肌梗死病因与院内死亡独立相关(HR 2.5,95%CI 1.3-4.9,p=0.009)。
- 常见并发症:需要肾脏替代治疗76%、血胸或心包填塞48%、需要外科翻修34%、纵隔炎28%、卒中28%。
- 成功桥接者中仅4/30(5%)接受VAD,心脏移植16/80(20%)、恢复10/80(12%)。
- 作者认为该策略适用于经过高度选择的年轻患者,作为决策桥接可避免浪费昂贵有限的资源。
适用人群与场景
- 2006年2月至2023年1月入住ECMO专用ICU、因难治性心源性休克接受外周V-A ECMO并转换为中央ECMO的患者。
- 排除:中央ECMO作为首选机械循环支持的患者。
研究设计与关键结果
- 研究类型:回顾性单中心研究;样本量80例;中位年龄44岁(IQR 29-53),女性与男性性别比0.6。
- 转换原因:难治性肺水肿为主要转换原因。
- 桥接结局:30例(38%)成功桥接,其中心脏移植16/80(20%)、恢复10/80(12%)、VAD 4/30(5%);其余50/80(62%)在中央ECMO上死亡。
- 并发症:需要肾脏替代治疗76%、血胸或心包填塞48%、需要外科翻修34%、纵隔炎28%、卒中28%。
- 生存:院内生存率31%,1年生存率27%。
- 独立相关因素:心肌梗死作为难治性心源性休克病因是唯一与院内死亡独立相关的变量(HR 2.5,95%CI 1.3-4.9,p=0.009)。
证据类型、等级与局限
- 证据类型:回顾性单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对经过高度选择的年轻、有真实心功能恢复或心脏移植机会的患者,从失败的外周ECMO转换为中央ECMO作为决策桥接是可行策略。
- 作者认为,该策略下中央ECMO允许对患者进行分诊,避免浪费昂贵有限的资源。
- 心肌梗死病因与院内死亡独立相关(HR 2.5,95%CI 1.3-4.9,p=0.009),提示该组患者转换后预后更差。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Peripheral veno-arterial extracorporeal membrane oxygenation (pECMO) has become the first-line device in refractory cardiogenic shock (rCS). Some pECMO complications can preclude any bridging strategies and a peripheral-to-central ECMO (cECMO) switch can be considered as a bridge-to-decision. We conducted this study to appraise the in-hospital survival and the bridging strategies in patients undergoing peripheral-to-central ECMO switch.
METHODS: This retrospective monocenter study included patients admitted to a ECMO-dedicated intensive care unit from February 2006 to January 2023. Patients with rCS requiring pECMO switched to cECMO were included. Patients were not included when the cECMO was the first mechanical circulatory support.
RESULTS: Eighty patients, with a median [IQR25-75] age of 44 [29-53] years at admission and a female-to-male sex ratio of 0.6 were included in the study. Refractory pulmonary edema was the main switching reason. Thirty patients (38%) were successfully bridged to: heart transplantation (n = 16/80, 20%), recovery (n = 10/80, 12%) and ventricle assist device (VAD, n = 4/30, 5%) while the others died on cECMO (n = 50/80, 62%). The most frequent complications were the need for renal replacement therapy (76%), hemothorax or tamponade (48%), need for surgical revision (34%), mediastinitis (28%), and stroke (28%). The in-hospital and one-year survival rates were 31% and 27% respectively. Myocardial infarction as the cause of the rCS was the only variable independently associated with in-hospital mortality (HR 2.5 [1.3-4.9], p = 0.009).
CONCLUSIONS: The switch from a failing pECMO support to a cECMO as a bridge-to-decision is a possible strategy for a very selected population of young patients with a realistic chance of heart function recovery or heart transplantation. In this setting, cECMO allows patients triage preventing from wasting expensive and limited resources.
参考来源
- Besnard A, Moyon Q, Lebreton G, et al. Peripheral-to-central extracorporeal corporeal membrane oxygenation switch in refractory cardiogenic shock patients: outcomes and bridging strategies. Ann Intensive Care. 2024. PMID: 39373870. doi:10.1186/s13613-024-01382-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。